About Lawrence Mehren
Lawrence Mehren is a chairman at Avery Therapeutics.
Lawrence Mehren reports to the SEC as a director, officer or major shareholder of 2 public companies: Accelerate Diagnostics (AXDX) and Ventana Medical Systems (VMSI).
Lawrence Mehren first appears on SEC filings in 2007.
Experience
This experience comes from Lawrence Mehren's profile and from SEC filings. For roles taken from filings, the years are when the filings name Lawrence Mehren in the role, so the role may have started earlier or lasted longer.
Avery Therapeutics, Inc. Current
Chairman of the Board
2022 – Present · Tucson, AZ
Develops a tissue-engineered heart graft for people with heart failure.
LD
Lumos Diagnostics Current
Vice Chairman
2021 – Present
HI
Helia Care, Inc.
Executive Chairman of the Board
2023 – 2025
AI
Accelerate Diagnostics, Inc
President and Chief Executive Officer (Retired) (2012 – 2020)
Director
2012 – 2020 · Public company (AXDX)
VI
Ventana Medical Systems Inc.
Chief Financial Officer
Head of Global Business (COO) (2007 – 2012)
2007 – 2012 · Public company (VMSI)
PB
PMCF Investment Banking
Managing Director, Head of Life Sciences
2000 – 2007
Key Colleagues at Startups
The people Lawrence Mehren works with at each company, as listed on that company's latest Form D.
Avery Therapeutics, Inc. · Form D, Sep 21, 2026
EN
Emile Nuwaysir
Director
Jordan Lancaster
Chief Executive Officer and director
SG
Steven Goldman
Chief Medical Officer